Showing results (181-190 of 385) with videos related to

Sort By:
Pageof 39
BMC Medical Informatics and Decision Making|December 16, 2014
Is pathology necessary to predict mortality among men with prostate-cancer?David Margel, David R Urbach, Lorraine L Lipscombe, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 27, 2017
Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohortAmar Bhindi, Bimal Bhindi, Girish S Kulkarni, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 2, 2020
Trimodal therapy in muscle invasive bladder cancer managementElvira Polo-Alonso, Cynthia Kuk, Georgi Guruli, et al.
The Canadian Journal of Urology|December 12, 2012
Perineural invasion on prostate biopsy does not predict adverse pathological outcomeMalik Elharram, David Margel, Antonio Finelli, et al.
Histopathology|August 31, 2018
Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data setMehdi Masoomian, Michelle R Downes, Joan Sweet, et al.
Plos One|September 11, 2010
A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistanceSevtap Savas, Laurent Briollais, Irada Ibrahim-zada, et al.
The Journal of Urology|July 27, 2016
Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active SurveillanceNathan Perlis, Rashid Sayyid, Andrew Evans, et al.
Plos One|April 30, 2019
Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?Marian S Wettstein, Jasjit K Rooprai, Clinsy Pazhepurackel, et al.
Urologic Oncology|May 5, 2010
BCAN Think Tank session 1: Overview of risks for and causes of bladder cancerAlexandre R Zlotta, Samuel M Cohen, Colin Dinney, et al.
Urologic Oncology|September 2, 2014
Molecular profiling of ETS gene rearrangements in patients with prostate cancer registered in REDEEM clinical trialNallasivam Palanisamy, Alexi Tsodikov, Wei Yan, et al.
Pageof 39